Riok1, A Novel Potential Target in MSI-High p53 Mutant Colorectal Cancer Cells

The vulnerabilities of cancer cells constitute a promising strategy for drug therapeutics. This paper integrates proteomics, bioinformatics, and cell genotype together with in vitro cell proliferation assays to identify key biological processes and potential novel kinases that could account, at leas...

Descripción completa

Detalles Bibliográficos
Autores principales: Shechter, Sharon, Ya’ar Bar, Sapir, Khattib, Hamdan, Gage, Matthew J., Avni, Dorit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10254355/
https://www.ncbi.nlm.nih.gov/pubmed/37298928
http://dx.doi.org/10.3390/molecules28114452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10254355/
https://www.ncbi.nlm.nih.gov/pubmed/37298928
http://dx.doi.org/10.3390/molecules28114452

Ejemplares similares